Association of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PET

dc.contributor.authorStage, Eddie
dc.contributor.authorRisacher, Shannon L.
dc.contributor.authorLane, Kathleen A.
dc.contributor.authorGao, Sujuan
dc.contributor.authorNho, Kwangsik
dc.contributor.authorSaykin, Andrew J.
dc.contributor.authorApostolova, Liana G.
dc.contributor.authorAlzheimer’s Disease Neuroimaging Initiative
dc.contributor.departmentNeurology, School of Medicineen_US
dc.date.accessioned2023-06-16T14:24:23Z
dc.date.available2023-06-16T14:24:23Z
dc.date.issued2022-05-11
dc.description.abstractIntroduction: We previously reported genetic associations of the top Alzheimer's disease (AD) risk alleles with amyloid deposition and neurodegeneration. Here, we report the association of these variants with [18F]flortaucipir standardized uptake value ratio (SUVR). Methods: We analyzed the [18F]flortaucipir scans of 352 cognitively normal (CN), 160 mild cognitive impairment (MCI), and 54 dementia (DEM) participants from Alzheimer's Disease Neuroimaging Initiative (ADNI)2 and 3. We ran step-wise regression with log-transformed [18F]flortaucipir meta-region of interest SUVR as the outcome measure and genetic variants, age, sex, and apolipoprotein E (APOE) ε4 as predictors. The results were visualized using parametric mapping at familywise error cluster-level-corrected P < .05. Results: APOE ε4 showed significant (P < .05) associations with tau deposition across all disease stages. Other significantly associated genes include variants in ABCA7 in CN, CR1 in MCI, BIN1 and CASS4 in MCI and dementia participants. Discussion: We found significant associations to tau deposition for ABCA7, BIN1, CASS4, and CR1, in addition to APOE ε4. These four variants have been previously associated with tau metabolism through model systems.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationStage E, Risacher SL, Lane KA, et al. Association of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PET. Alzheimers Dement (Amst). 2022;14(1):e12308. Published 2022 May 11. doi:10.1002/dad2.12308en_US
dc.identifier.urihttps://hdl.handle.net/1805/33813
dc.language.isoen_USen_US
dc.publisherAlzheimer’s Associationen_US
dc.relation.isversionof10.1002/dad2.12308en_US
dc.relation.journalAlzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoringen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourcePMCen_US
dc.subjectAlzheimer's diseaseen_US
dc.subjectAlzheimer's Disease Neuroimaging Initiativeen_US
dc.subjectFlortaucipiren_US
dc.subjectImaging geneticsen_US
dc.subjectRisk genesen_US
dc.titleAssociation of the top 20 Alzheimer's disease risk genes with [18F]flortaucipir PETen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
DAD2-14-e12308.pdf
Size:
1.29 MB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: